Choudhary Narendra S, Saha Sujeet K, Saigal Sanjiv, Gautam Dheeraj, Saraf Neeraj, Rastogi Amit, Bhangui Prashant, Thiagrajan Srinivasan, Soin Arvinder S
Institute of Liver Transplantation and Regenerative Medicine, Medanta, the Medicity, India.
Department of Histopathology, Medanta, the Medicity, Gurgaon, India.
J Clin Exp Hepatol. 2020 Jul-Aug;10(4):334-338. doi: 10.1016/j.jceh.2019.12.004. Epub 2019 Dec 27.
There are few data on genetic relation of the donor and outcomes in living donor liver transplantation (LDLT) recipients. We compared outcomes of LDLT between recipients of genetically related and unrelated donors in a large single-center series.
The study included 1372 adult, ABO-compatible, primary LDLT recipients, who received a graft from either a first-degree relative (parent, sibling, son, or daughter; n = 756) or unrelated donor (spouse or relative of the spouse; n = 616).
The mean age of the recipients with a related donor was 50.2 ± 10.8 years compared with 47.3 ± 9.3 years for recipients with unrelated donors ( = 0.000). Chronic rejection was significantly more common in the genetically unrelated donor group than in the genetically related donor group (28 [4.5%] versus 9 [1.1%]; = 0.000) at a mean follow-up of 37 months (15-95 months). There were no significant differences in other outcomes between the 2 groups. The 12-month and 36-month survival between the unrelated and related groups was 87.6% versus 90%, and 86.3% versus 89.7% respectively ( = 0.115). The multivariate analysis revealed genetically unrelated donors (odds ratio [OR]: 3.88, 95% confidence interval [CI]: 1.80-8.34, = 0.001) and history of acute cellular rejection (OR: 3.39, 95% CI: 1.68-6.81, = 0.001) as predictors of chronic rejection.
Although chronic rejection was found to be more common in genetically unrelated donors, the patient survival after LDLT was similar.
关于活体肝移植(LDLT)受者中供者与预后的遗传关系的数据较少。我们在一个大型单中心队列中比较了遗传相关供者和非遗传相关供者的LDLT受者的预后。
该研究纳入了1372例成年、ABO血型相合的初次LDLT受者,他们接受的移植物来自一级亲属(父母、兄弟姐妹、儿子或女儿;n = 756)或非亲属供者(配偶或配偶的亲属;n = 616)。
遗传相关供者受者的平均年龄为50.2±10.8岁,而非遗传相关供者受者的平均年龄为47.3±9.3岁(P = 0.000)。在平均37个月(15 - 95个月)的随访中,非遗传相关供者组的慢性排斥反应明显比遗传相关供者组更常见(28例[4.5%]对9例[1.1%];P = 0.000)。两组在其他预后方面无显著差异。非亲属组和亲属组的12个月和36个月生存率分别为87.6%对90%,以及86.3%对89.7%(P = 0.115)。多因素分析显示,非遗传相关供者(比值比[OR]:3.88,95%置信区间[CI]:1.80 - 8.34,P = 0.001)和急性细胞排斥反应史(OR:3.39,95% CI:1.68 - 6.81,P = 0.001)是慢性排斥反应的预测因素。
虽然发现非遗传相关供者的慢性排斥反应更常见,但LDLT后的患者生存率相似。